Headlines Covid-19 Specialties Trending Feeds Videos

OncoAlert Colloquium 2020

posted 1 day


Mashup Score: 1

VJOncology - End-of-year wrap-up presenting the biggest findings and changes to clinical practice that have happened during...

Enfortumab Vedotin-ejfv in Previously Treated Advanced Urothelial Carcinoma – The ASCO Post

posted 11 hours


Mashup Score: 1

ascopost.com - By Matthew Stenger Posted: 3/1/2021 11:40:00 AM Last Updated: 3/1/2021 1:35:39 PM As reported in The New England Journal of Medicine by Powles et...

Model Proposed to Guide Use of Adjuvant Radiotherapy for MIBC – Renal and Urology News

posted 1 day


Renal and Urology News - Pathologic features can identify patients with muscle-invasive bladder cancer who may benefit from adjuvant radiotherapy after radical...

Debate Ensues With Integrating Multimodal Approaches in RCC, Sequencing Agents in Bladder Cancer

posted 1 day


OncLive - During the question-and-answer portion of the virtual Institutional Perspectives in Cancer webinar, Earle Burgess, MD, and colleagues provide insight into how they are navigating...

FDA Grants Priority Review to Vicineum for High-Risk, BCG-Unresponsive NMIBC

posted 1 day


OncLive - February 17, 2021 – The FDA has accepted and granted a priority review designation to the biologics license application for Vicineum for use in...

  • The @US_FDA will review the application for Vicineum within 6 months, compared with the standard 10 months from the date of the filing. The FDA is not planning to hold an advisory committee meeting to discuss the application. #blcsm https://t.co/wfyE4GEhiE

Predicting long-term benefit from ICIs in mUC

posted 20 hours


VJOncology - Srikala Sridhar, MD, FRCPC, Princess Margaret Cancer Centre, Toronto, ON, describes a retrospective, post-hoc analysis of two clinical studies...